Indigenous Australians experience a greater burden of sexually transmitted infections, however are less likely than the general population to access sexual health services. We examined the effectiveness of an Indigenous cultural appropriateness audit in assessing a sexual health clinic with low rates of Indigenous clients.
The audit was developed to identify cultural barriers within a health service and offer recommendations to address these. The data collection process involved an interview with the director of the clinic (conducted by Indigenous health workers independent of the clinic) and an online survey of all staff. The objectives were to examine the cultural appropriateness of the clinic’s policies and procedures, consultation processes, physical environment, promotional materials, community engagement and staff training. The Indigenous workers analysed the data and provided recommendations.
Recommendations included completing an Aboriginal Health Impact Statement, ensuring Indigenous status is correctly recorded in all client files, including Indigenous service providers in service planning, requiring all staff attend cultural respect training, increasing Indigenous employment opportunities, circulating a monthly Indigenous performance report and implementing an Indigenous client feedback process. Support was provided to assist the clinic in implementing these recommendations. The quarterly percentages of Aboriginal and Torres Strait Islander clients increased from 1.7% of all clinic clients six months prior to 6.2% six months post commencing implementation of audit recommendations. These changes have been sustained at one year post project and occasions of service for indigenous clients continue to increase.
Performing a cultural audit of a clinical service can lead to increased engagement and awareness of Aboriginal and Torres Strait Islander peoples and their needs. The project outcomes demonstrate the efficacy of such an audit in initiating sustainable cultural improvements.
The case is of a 30 year-old HIV positive Zimbabwean woman (UK resident) who arrived in Australia in January 2011 on a one-year working visa. She was diagnosed with HIV in 2003 in the UK and commenced on Atripla® in 2005. She was first seen in Adelaide in May 2011, requesting a script for Atripla.®.
Background: Liquid based anal Papanicolaou smears, followed by High Resolution Anoscopy (HRA) guided biopsies are increasingly being advocated to identify areas of High Grade Anal Intraepithelial Neoplasia (HGAIN). We hypothesized that the ability to identify HGAIN would increase with experience of the anoscopist, and that comparison with contemporary Papanicolaou smears might yield insights into technical abilities.
Despite the high proportion of young people annually accessing general practices, including Aboriginal Medical Services (AMS), testing for Chlamydia trachomatis remains relatively low in urban areas. A project officer was employed within the Institute of Urban Indigenous Health (IUIH) to serve a mentoring and facilitation role for the SE Queensland network of AMS and their sexual health workers, with a view to improving testing, management and follow-up of chlamydia and other STIs by community controlled medical services.
Monocytes are a heterogeneous cell population having specialised functions and differing phenotype. They are a link between innate immune system and adaptive immune system therefore, to identify if immune activation exists in HIV-1 individuals with controlled virema and recovered CD4 T cell counts, we assessed cell surface monocyte activation markers (MAM) within the monocyte subsets.
Involving consumers in healthcare decisions is important for high quality care. We previously tested a brief, consumer-led intervention consisting of three questions in a trial employing trained, standardized patients. The intervention enhanced discussion of evidence and increased patient involvement. We now report a research translation study which tested implementation with real patients at a reproductive and sexual health clinic.
Case presentation: A 27 year-old Vietnamese man was diagnosed with HIV in April 2012 when he presented with cerebrospinal fluid (CSF)-culture positive Cryptococcus neoformans meningitis. CD4 count was 4 cells/µL and HIV viral load 228827 copies/mL. He was treated with two weeks of amphotericin B (0.7mg/kg/day) and 5-fluorocytosine (25mg/kg/QID), followed by consolidation and secondary prophylaxis with fluconazole. CSF cultures were negative at two weeks. A ventriculo-peritoneal shunt was inserted to manage persistently raised intracranial pressure and had to be replaced two weeks later due to bacterial shunt infection. Antiretroviral therapy (ART) was commenced after four weeks of treatment, and by September 2012, CD4 count was 107 cells/L and viral load 150 copies/mL.